CC5 Stock Overview
Engages in the research, development, and commercialization of technology solutions for medical industry in Australia, the United States, Sweden, the United Kingdom, and Germany. More details
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 3/6 |
| Dividends | 0/6 |
My Notes
Capture your thoughts, links and company narrative
Clever Culture Systems Limited Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | AU$0.02 |
| 52 Week High | AU$0.038 |
| 52 Week Low | AU$0.009 |
| Beta | 1.67 |
| 1 Month Change | 5.26% |
| 3 Month Change | 25.00% |
| 1 Year Change | 100.00% |
| 3 Year Change | -83.33% |
| 5 Year Change | -87.88% |
| Change since IPO | -90.91% |
Recent News & Updates
Recent updates
Shareholder Returns
| CC5 | AU Medical Equipment | AU Market | |
|---|---|---|---|
| 7D | 17.6% | 1.1% | -0.06% |
| 1Y | 100.0% | 2.8% | 9.0% |
Return vs Industry: CC5 exceeded the Australian Medical Equipment industry which returned 1.5% over the past year.
Return vs Market: CC5 exceeded the Australian Market which returned 8.3% over the past year.
Price Volatility
| CC5 volatility | |
|---|---|
| CC5 Average Weekly Movement | 13.6% |
| Medical Equipment Industry Average Movement | 9.2% |
| Market Average Movement | 8.0% |
| 10% most volatile stocks in AU Market | 16.6% |
| 10% least volatile stocks in AU Market | 3.0% |
Stable Share Price: CC5's share price has been volatile over the past 3 months compared to the Australian market.
Volatility Over Time: CC5's weekly volatility has decreased from 25% to 14% over the past year, but is still higher than 75% of Australian stocks.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2004 | 19 | Brent Barnes | www.lbtinnovations.com |
Clever Culture Systems Limited engages in the research, development, and commercialization of technology solutions for medical industry in Australia, the United States, Sweden, the United Kingdom, and Germany. The company offers Automated Plate Assessment System (APAS) Independence, a solution that automates the imaging, analysis, and interpretation of microbiology culture plates primarily for microbiology laboratories and pharmaceutical manufacturing sector; APAS Analysis Modules, a software algorithm that enables the screening of microbiology culture plates collected during environmental monitoring; and APAS PharmaQC, an artificial intelligence for culture plate reading. It also develops APAS intelligent imaging technology for various applications, which includes wound treatment, histopathology, and antimicrobial susceptibility testing.
Clever Culture Systems Limited Fundamentals Summary
| CC5 fundamental statistics | |
|---|---|
| Market cap | AU$35.15m |
| Earnings (TTM) | -AU$3.74m |
| Revenue (TTM) | AU$1.26m |
28.0x
P/S Ratio-9.4x
P/E RatioIs CC5 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| CC5 income statement (TTM) | |
|---|---|
| Revenue | AU$1.26m |
| Cost of Revenue | AU$149.00k |
| Gross Profit | AU$1.11m |
| Other Expenses | AU$4.85m |
| Earnings | -AU$3.74m |
Last Reported Earnings
Jun 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | -0.0021 |
| Gross Margin | 88.14% |
| Net Profit Margin | -297.77% |
| Debt/Equity Ratio | 71.9% |
How did CC5 perform over the long term?
See historical performance and comparisonCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2025/01/03 06:02 |
| End of Day Share Price | 2025/01/03 00:00 |
| Earnings | 2024/06/30 |
| Annual Earnings | 2024/06/30 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Clever Culture Systems Limited is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|